This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2016-2024.
Company Filing History:
Years Active: 2016-2024
Certainly! Here is an article about inventor Rocco Bussolati:
Title: Innovator Spotlight: Rocco Bussolati's Contributions to Pharmaceutical Science
Introduction:
Rocco Bussolati, a talented inventor based in Parma, Italy, has made significant strides in the field of pharmaceuticals. With a total of 6 patents to his name, Bussolati has been instrumental in advancing the development of new medications for the treatment of respiratory diseases.
Latest Patents:
Bussolati's latest patents focus on a groundbreaking process for the preparation of a PDE4 inhibitor. These compounds exhibit potent phosphodiesterase (PDE4) inhibitory activity, making them valuable assets in the pharmaceutical industry. The patented process includes the isolation of the compound through crystallization and its formulation into inhalable pharmaceutical compositions.
Career Highlights:
Currently employed at Chiesi Farmaceutici S.p.A., a renowned pharmaceutical company, Bussolati has garnered recognition for his innovative research and development efforts. His commitment to creating novel solutions for respiratory ailments has positioned him as a key figure in the company's success.
Collaborations:
Bussolati's collaborative spirit is evident through his partnerships with colleagues Alessandro Falchi and Emilio Lutero. Together, they have worked on groundbreaking projects that have contributed to the advancement of pharmaceutical science and the enhancement of patient care.
Conclusion:
In conclusion, Rocco Bussolati's dedication to innovation and his contributions to the pharmaceutical field have not gone unnoticed. His inventive spirit and commitment to improving healthcare highlight him as a valuable asset to both Chiesi Farmaceutici S.p.A. and the broader scientific community. Bussolati's work serves as a testament to the power of creativity and collaboration in driving progress within the realm of pharmaceutical research.
